力诺药包拟授出808.27万股限制性股票

Core Viewpoint - The company, Linuo Pharmaceutical (301188.SZ), has announced a restricted stock incentive plan for 2026, aiming to motivate its employees through equity ownership [1] Group 1: Incentive Plan Details - The company plans to grant a total of 8.0827 million restricted shares to 28 incentive recipients [1] - The grant price for the restricted shares is set at 9.03 yuan per share [1] - The effective period of the incentive plan will last from the date of grant until all restricted shares are vested or become invalid, with a maximum duration of 36 months [1]